Carmichael Times
Like Us On Facebook Follow Us On Twitter
Founded 1981
Serving Carmichael and Sacramento County
 
  Home Community Finance Employment Your Home Your Money Your Kids Your Health  
  Business Education Politics Police & Fire Veterans' News Real Estate Consumer News Taxes  
  Religion Food Recipes Gardening Car Care Fashion Beauty Pets  
  Lifestyles Sports Feature Writers Events Environment Human Interest Technology Travel  
 
50% of Hosting for your Website at GoDaddy.com! Local Classified Advertising
Pay Legal Ads Online
Messenger Publishing Group
Shop Local Carmichael Rewards Program
Constant Contact




Your Health

Breakthrough Research Reveals Pathway of Fibromyalgia

First Diagnostic Test Now Available
Posted: 5/22/2013

New research confirms fibromyalgia is an immune system disorder
New research confirms fibromyalgia is an immune system disorder.

(NAPSI)—For decades, debate has raged over whether fibromyalgia is a real medical disease. Despite the fact that fibromyalgia affects more than 12.3 million people in the United States—comparable to the number of people affected by cancer—some clinicians believe fibromyalgia is nothing more than a “syndrome.” When patients complain of chronic pain, diffuse muscle and joint tenderness, depression, mental fog, digestive troubles, severe fatigue, insomnia and other unbearable symptoms, they’ve often been told the problem is “in their heads.”

Recently published breakthrough research conducted at the University of Illinois College of Medicine at Chicago should end the debate—and stigma faced by fibromyalgia patients—once and for all. These studies, comparing fibromyalgia patients to healthy people, confirm that fibromyalgia is an immune system disorder.

The identification of this immune system pathway was not only honored with the 2012 American Association for Clinical Chemistry’s “Outstanding Research in Clinical and Diagnostic Immunology” award; it has also led to the first objective test capable of making a diagnosis of fibromyalgia.

“What we discovered over years of research is that fibromyalgia patients have an abnormal immune system,” said Bruce S. Gillis, MD, MPH, lead researcher and founder of EpicGenetics. “These peer-reviewed results have finally been able to ‘tear back the curtain’ to reveal that fibromyalgia is an immune system dysregulation disease relating to the production of protein molecules called chemokines and cytokines by a certain type of white blood cell.”

On average, fibromyalgia patients spend 3-5 painful years seeking a diagnosis, and $4,800-$9,300 annually on associated medical costs. By comparison, The FM Test, which costs $744, is a quick, simple blood test that offers conclusive results, usually in a week or less—a fraction of the time and money currently spent by patients seeking a diagnosis.

Anyone with fibromyalgia symptoms can have his or her doctor order the test. Alternatively, patients may take a simple questionnaire at www.TheFMTest.com and utilize an FM Test physician to request a test. Those already diagnosed with fibromyalgia can take the test to confirm and establish a baseline that can be used to track treatment effectiveness.

“The FM Test represents an objective biomarker that will prove useful in the diagnosis of an enigmatic disease,” said Ernest Brahn, MD, professor of medicine, Division of Rheumatology, at the UCLA School of Medicine.

Advertisers

left Pause Right
 

 




About The Carmichael Times | Copyright Notice
Carmichael Times| Paul V. Scholl, Publisher
P.O. Box 14 | Carmichael, CA 95609-0014 | Telephone: 916-773-1111 | Fax Line 916-773-2999
Email: publisher@MPG8.com | Site Designed and Hosted by TheSiteBarn.com
ISSN#: 1948-1918

Like Us On Facebook Follow Us On Twitter